Certara Overview
- Status
-
Public
- Employees
-
1,546
- Stock Symbol
-
CERT
- Investments
-
22
- Share Price
-
$10.76
- (As of Monday Closing)
Certara General Information
Description
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
Contact Information
Website
www.certara.comCorporate Office
- 4 Radnor Corporate Center
- Suite 350
- Radnor, PA 19087
- United States
Corporate Office
- 4 Radnor Corporate Center
- Suite 350
- Radnor, PA 19087
- United States
Certara Timeline
Certara Stock Performance
As of 16-Jun-2025, Certara’s stock price is $10.76. Its current market cap is $1.75B with 162M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $10.76 | $11.01 | $8.63 - $16.93 | $1.75B | 162M | 2.07M | -$0.02 |
Certara Financials Summary
As of 31-Mar-2025, Certara has a trailing 12-month revenue of $394M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 1,726,790 | 1,787,969 | 2,842,719 | 2,660,815 |
| Revenue | 394,498 | 385,148 | 354,337 | 335,644 |
| EBITDA | 83,586 | 72,369 | 23,844 | 88,998 |
| Net Income | (2,625) | (12,051) | (55,357) | 14,731 |
| Total Assets | 1,561,011 | 1,575,104 | 1,563,140 | 1,572,922 |
| Total Debt | 304,632 | 311,897 | 302,567 | 308,134 |
Certara Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Certara Comparisons
Industry
Financing
Details
Certara Competitors (13)
One of Certara’s 13 competitors is Metrum Research Group, a Corporation company based in Simsbury, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Metrum Research Group | Corporation | Simsbury, CT | ||||
| SeraCare | Formerly PE-Backed | Milford, MA | ||||
| BioBlocks | Corporate Backed or Acquired | Hamilton, NJ | ||||
| Cyclica | Formerly VC-backed | Toronto, Canada | ||||
| AbCellera Biologics | Formerly VC-backed | Vancouver, Canada |
Certara Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Certara Patents
Certara Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250060864-A1 | Graphical user interface for providing automated, real-time interactive word processing assistance to a user | Pending | 17-Aug-2023 | ||
| US-20250061961-A1 | Machine-learning models to create, update, validate, and/or assess the comprehensiveness of a mechanistic model of biological systems | Pending | 17-Aug-2023 | ||
| EP-4384641-A1 | Methods and apparatus utilising liquid biopsy to identify and monitor pharmacodynamic markers of disease | Pending | 10-Aug-2021 | ||
| US-20240200144-A1 | Methods and apparatus utilising liquid biopsy to identify and monitor pharmacodynamic markers of disease | Pending | 10-Aug-2021 | ||
| US-20220328140-A1 | Methods and apparatus for therapeutic feasibility assessment using quantitative systems pharmacology and rule-based reasoning systems | Inactive | 05-Apr-2021 | G16C20/30 |
Certara Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Certara Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Certara Investments & Acquisitions (22)
Certara’s most recent deal was a Merger/Acquisition with ChemAxon for . The deal was made on 01-Oct-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ChemAxon | 01-Oct-2024 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
| Applied BioMath | 12-Dec-2023 | Merger/Acquisition | Drug Discovery | ||
| Formedix | 10-Oct-2023 | Merger/Acquisition | Other Healthcare Technology Systems | ||
| Drug Interaction Solutions | 20-Jun-2023 | Merger/Acquisition | Other Healthcare Services | ||
| Vyasa Analytics | 28-Dec-2022 | Merger/Acquisition | Media and Information Services (B2B) |
Certara ESG
Risk Overview
Risk Rating
Updated April, 04, 2025
16.11 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,673
Rank
Percentile
Healthcare
Industry
of 564
Rank
Percentile
Health Care IT Services
Subindustry
of 35
Rank
Percentile
Certara Exits (3)
Certara’s most recent exit was on 30-Apr-2002 from Signase. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Signase | 30-Apr-2002 | Completed |
|
||
| Signase | 01-May-2000 | Completed |
|
||
| Arena Pharmaceuticals | 22-Feb-1999 | Later Stage VC | Completed |
|
Certara Affiliates
Subsidiaries (7)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Vyasa Analytics | Newburyport, MA | 2016 | |
| Applied BioMath | Concord, MA | 2013 | |
| Pinnacle 21 | Radnor, PA | 2011 | |
| ChemAxon | Budapest, Hungary | 1998 | |
| Analytica Laser | London, United Kingdom | 1997 |
Certara FAQs
-
Where is Certara headquartered?
Certara is headquartered in Radnor, PA.
-
What is the size of Certara?
Certara has 1,546 total employees.
-
What industry is Certara in?
Certara’s primary industry is Drug Delivery.
-
Is Certara a private or public company?
Certara is a Public company.
-
What is Certara’s stock symbol?
The ticker symbol for Certara is CERT.
-
What is the current stock price of Certara?
As of 16-Jun-2025 the stock price of Certara is $10.76.
-
What is the current market cap of Certara?
The current market capitalization of Certara is $1.75B.
-
What is Certara’s current revenue?
The trailing twelve month revenue for Certara is $394M.
-
Who are Certara’s competitors?
Metrum Research Group, SeraCare, BioBlocks, Cyclica, and AbCellera Biologics are some of the 13 competitors of Certara.
-
What is Certara’s annual earnings per share (EPS)?
Certara’s EPS for 12 months was -$0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
